Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study

BACKGROUND: To assess the prognostic value of progesterone receptor (PR) expression in patients with hormone receptor-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer subgroups. METHODS: A retrospective review of breast cancer patients who underwent mastectomy or b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jia-Yuan, Wu, San-Gang, Li, Feng-Yan, Lin, Huan-Xin, He, Zhen-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807933/
https://www.ncbi.nlm.nih.gov/pubmed/27051305
http://dx.doi.org/10.2147/OTT.S98666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807933/
https://www.ncbi.nlm.nih.gov/pubmed/27051305
http://dx.doi.org/10.2147/OTT.S98666

Ejemplares similares